FAKTOR-FAKTOR YANG BERHUBUNGAN DENGAN PENGENDALIAN TEKANAN DARAH PASIEN HIPERTENSI PENGGUNA CAPTOPRIL DAN AMLODIPIN

Yopi Rikmasari; Noprizon Noprizon; Yunita Listiani Imanda

doi:10.36341/jops.v7i2.4475

Yopi Rikmasari Sekolah Tinggi Ilmu Farmasi Bhakti Pertiwi
Noprizon Noprizon Sekolah Tinggi Ilmu Farmasi Bhakti Pertiwi
Yunita Listiani Imanda Sekolah Tinggi Ilmu Farmasi Bhakti Pertiwi

: https://doi.org/10.36341/jops.v7i2.4475

Abstract

Objective: Captopril and amlodipine are the antihypertensive drugs most widely used in primary health care facilities to control blood pressure in hypertensive patients, however, blood pressure control is influenced by many factors other than drug use. This study aims to analyze the differences in the effectiveness of captopril and amlodipine as well as factors related to controlling blood pressure in hypertensive patients

Methods: The research design used cross-sectional correlational analysis using accidental sampling at two community health centers in the city of Palembang. Data sources are secondary data (medical records) and primary data (MMAS-8 questionnaire). Effectiveness is assessed by reducing systolic and diastolic blood pressure. Data were analyzed using descriptive statistics, Mann-Whitney and chi-square tests.

Results: The research subjects were 94 people. The difference in the effectiveness of captopril and amlodipine using the Mann-Whitney test showed p=0.625 for systolic blood pressure and p=0.916 for diastolic blood pressure. The results of the chi-square test showed that the factors age (p=0.035), presence of comorbidities (p=0.015), accuracy of drug selection (p=0.009), medication compliance (p=0.011) were related to blood pressure control, while the gender factor (p=0.418 ), degree of hypertension (p=0.095), duration of therapy (p=0.074) and type of medication (p=0.216) were not related to blood pressure control.

Conclusion: There was no difference in the effectiveness of captopril and amlodipine in this study. Factors related to blood pressure control are age, presence of comorbidities, choice of medication and adherence to medication

Keywords: hypertension, captopril, amlodipine, targeted therapy

References

Alfian, S. D., Putra, A.M.P., 2016, Medication Adherence Contributes to an Improved Quality of Life in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study, Diabetes Therapy, 7(4): 755–764. doi: 10.1007/s13300-016-0203-x.
Andhyka, I., Sidrotullah, M. and Elvvi, E., 2019, Profil Efektivitas Obat Hipertensi Captopril dan Amlodipin Pada Pasien Hipertensi Rawat Jalan di Wilayah Kerja Puskesmas Selaparang Periode Juni Tahun 2017, Jurnal Ilmu Kesehatan dan Farmasi, 7(1): 5–9
Barreto, M. da S., Matsuda, L. M. and Marcon, S. S., 2016, Factors associated with inadequate blood pressure control in patients of primary care, Escola Anna Nery - Revista de Enfermagem, 20(1): 114–120. doi: 10.5935/1414-8145.20160016.
Burnier, M. and Egan, B. M., 2019, Adherence in Hypertension: A Review of Prevalence, Risk Factors, Impact, and Management, Circulation Research, 124(7); 1124–1140. doi: 10.1161/CIRCRESAHA.118.313220.
Carey, R. M, Muntner, P., Bosworth, H.B., and Whelton, P.K., 2018, Prevention and Control of Hypertension: JACC Health Promotion Series, Journal of the American College of Cardiology, 72(11): 1278–1293. doi: 10.1016/j.jacc.2018.07.008.
Dipiro, J. T, Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G., Posey, L.M., 2017, Pharmacotherapy A Pathophysiologic Approach. 10th ed, Mc Graw Hill Education. 10th edn. New York, Chicago, San Francisco, Athens, London, Madrid, Mexico City, Milan, New Delhi, Singapore, Sydney, Toronto.
Gakidou, E., 2017, Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016, The Lancet, 390(10100): 1345–1422. doi: 10.1016/S0140-6736(17)32366-8.
IDI., 2014, Panduan Praktik Klinis Bagi Dokter di Fasilitas Pelayanan Kesehatan Primer. Revisi, Ikatan Dokter Indonesia. Revisi. Jakarta.
James, P. A. Oparil, S., Carter, B.L., Cushmann, W.C, Dennison-Himmelfarb, C., Handler, J., Lackland, D.T., Le-Fevre, M.L., MacKenzie, T.D., Ogedegbe, O., Smith, S.C., Svetkey, L.P., Taler, S.J., Towsend, R.R., Wright, J.T., Narva, A.S., and Ortiz, E., 2014, 2014 Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8), JAMA - Journal of the American Medical Association, 311(5): 507–520. doi: 10.1001/jama.2013.284427.
Kemenkes., 2013, Riset Kesehatan Dasar Tahun 2013, Badan Penelitian dan Pengembangan Kesehatan Kementrian Kesehatan Republik Indonesia. Jakarta.
Kemenkes., 2017, Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/659/2017 Tentang Formularium Nasional. Indonesia.
Kemenkes., 2019, Laporan Nasional Riset Kesehatan Dasar, Kementrian Kesehatan Republik Indonesia. Jakarta.
PERKI., 2015, Pedoman Tatalaksana Hipertensi Pada Penyakit Kardiovaskular. 1st ed. Jakarta: Indonesian Heart Association.
Rikmasari, Y. and Noprizon., 2020, Hubungan Kepatuhan Menggunakan Obat Dengan Keberhasilan Terapi Pasien Hipertensi Di RS PT Pusri Palembang, SCIENTIA : Jurnal Farmasi dan Kesehatan, 10(1): 97–103. doi: 10.36434/scientia.v10i1.202.
Rikmasari, Y., Rendowati, A. and Putri, A., 2020, Faktor - faktor yang mempengaruhi kepatuhan menggunakan obat antihipertensi : cross sectional study di Puskesmas Sosial Palembang, Jurnal Penelitian Sains, 22(2): 87–94.
Suhadi, R. Atthobari, J., Irawan, B., Dwiprahasto, I., 2013, Hubungan Faktor Komorbiditas, Intensifikasi Terapi dan Pengendalian Tekanan Darah, Jurnal Farmasi Sains dan Komunitas, 10(1): 1–8.
Unger, T., Borghi, C., Charchar, F., Khan, N.A., Poulter, N.R., Prabhakaran, D., Ramirez, A., Schaich., M., Stergiou, G.S., Tomaszewski, M., Wainford, R.D., Williams, B., Schutte, A,E., 2020, International Society of Hypertension Global Hypertension Practice Guidelines, Hypertension, 75(6): 1334–1357. doi: 10.1161/HYPERTENSIONAHA. 120.15026.
WHO., 2003, Adherence To Long-Term Therapies : Evidence for Action, World Health Organization.
Williams, B., 2018, 2018 practice guidelines for the management of arterial hypertension of the European society of cardiology and the European society of hypertension ESC/ESH task force for the management of arterial hypertension, European Heart Journal, 36(12): 2284-2309 doi: 10.1097/HJH.0000000000001961.
Winta, A. E., Setiyorini, E. and Wulandari, N. A, 2018, Hubungan Kadar Gula Darah Dengan Tekanan Darah Pada Lansia Penderita Diabetes Tipe 2, 5(2): 163–171. doi: 10.26699/jnk.v5i2.ART.p163.

FACTORS RELATED TO BLOOD PRESSURE CONTROL OF HYPERTENSIVE PATIENTS USING CAPTOPRIL AND AMLODIPINE

Abstract

References